JSM2025
Back to all people

Parag Garhyan

Global PK/PD/Pharmacometrics, Eli Lilly and Company
1 appearance in the program

Sessions & presentations

Improving Dose Selection in Drug Development: Efficient Modeling Approaches Based on Early Data
Presentation: Stronger Together: Harnessing PKPD and statistical insights for drug development decisions at Eli Lilly and Company
Invited Paper Session · Sun, Aug 3 , 4:00 PM
Speaker
↑